Mado Gilanton

PRESIDENT, APAISER S&C

Mado is a member of the Rare Disease Alliance and a member of the governance of the Chiari Syringo-MAVEM Reference Centre. At 64, she suffers from syringomyelia and chiari, two rare pathologies of the spinal cord and cerebellum. At the Scientific Board of APAISER S & C she developed a study on the medical use of cannabis. She presented to the ANSM CSST on “the real life of patients who use cannabis.”

Thank you for your interest!

Our team appreciates your engagement, and one of our managers will reach out to you shortly.